The biotechnology company, Blis Technologies, has been censured by the Markets Disciplinary Tribunal and fined 30-thousand dollars for failing to share information with the market that did materially impact its share price.
Recent stories from Business News
Get the RNZ app
for easy access to all your favourite programmes
